img

Global Retinal Drugs and Biologics Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Retinal Drugs and Biologics Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Retinal Drugs and Biologics report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Retinal Drugs and Biologics market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospitals and Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Retinal Drugs and Biologics industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Retinal Drugs and Biologics key manufacturers include ALLERGAN, AbbVie, Alimera Sciences, Janssen Biotech, Swedish Orphan Biovitrum, Roche, Bristol-Myers Squibb, Genzyme and Genentech, etc. ALLERGAN, AbbVie, Alimera Sciences are top 3 players and held % sales share in total in 2022.
Retinal Drugs and Biologics can be divided into Age Related Macular Degeneration, Diabetic Retinopathy, Ocular Inflammatory Disease (Uveitis) and Macular Hole, etc. Age Related Macular Degeneration is the mainstream product in the market, accounting for % sales share globally in 2022.
Retinal Drugs and Biologics is widely used in various fields, such as Hospitals, Clinics and Others,, etc. Hospitals provides greatest supports to the Retinal Drugs and Biologics industry development. In 2022, global % sales of Retinal Drugs and Biologics went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Retinal Drugs and Biologics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


ALLERGAN
AbbVie
Alimera Sciences
Janssen Biotech
Swedish Orphan Biovitrum
Roche
Bristol-Myers Squibb
Genzyme
Genentech
OCULAR THERAPEUTIX
Bausch & Lomb
UCBCares
Segment by Type
Age Related Macular Degeneration
Diabetic Retinopathy
Ocular Inflammatory Disease (Uveitis)
Macular Hole

Segment by Application


Hospitals
Clinics
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Retinal Drugs and Biologics market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Retinal Drugs and Biologics, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Retinal Drugs and Biologics industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Retinal Drugs and Biologics in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Retinal Drugs and Biologics introduction, etc. Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Retinal Drugs and Biologics market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Retinal Drugs and Biologics Market Overview
1.1 Retinal Drugs and Biologics Product Overview
1.2 Retinal Drugs and Biologics Market Segment by Type
1.2.1 Age Related Macular Degeneration
1.2.2 Diabetic Retinopathy
1.2.3 Ocular Inflammatory Disease (Uveitis)
1.2.4 Macular Hole
1.3 Global Retinal Drugs and Biologics Market Size by Type
1.3.1 Global Retinal Drugs and Biologics Market Size Overview by Type (2018-2034)
1.3.2 Global Retinal Drugs and Biologics Historic Market Size Review by Type (2018-2024)
1.3.3 Global Retinal Drugs and Biologics Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Retinal Drugs and Biologics Sales Breakdown by Type (2018-2024)
1.4.2 Europe Retinal Drugs and Biologics Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Retinal Drugs and Biologics Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Retinal Drugs and Biologics Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Retinal Drugs and Biologics Sales Breakdown by Type (2018-2024)
2 Global Retinal Drugs and Biologics Market Competition by Company
2.1 Global Top Players by Retinal Drugs and Biologics Sales (2018-2024)
2.2 Global Top Players by Retinal Drugs and Biologics Revenue (2018-2024)
2.3 Global Top Players by Retinal Drugs and Biologics Price (2018-2024)
2.4 Global Top Manufacturers Retinal Drugs and Biologics Manufacturing Base Distribution, Sales Area, Product Type
2.5 Retinal Drugs and Biologics Market Competitive Situation and Trends
2.5.1 Retinal Drugs and Biologics Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Retinal Drugs and Biologics Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Retinal Drugs and Biologics as of 2022)
2.7 Date of Key Manufacturers Enter into Retinal Drugs and Biologics Market
2.8 Key Manufacturers Retinal Drugs and Biologics Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Retinal Drugs and Biologics Status and Outlook by Region
3.1 Global Retinal Drugs and Biologics Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Retinal Drugs and Biologics Historic Market Size by Region
3.2.1 Global Retinal Drugs and Biologics Sales in Volume by Region (2018-2024)
3.2.2 Global Retinal Drugs and Biologics Sales in Value by Region (2018-2024)
3.2.3 Global Retinal Drugs and Biologics Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Retinal Drugs and Biologics Forecasted Market Size by Region
3.3.1 Global Retinal Drugs and Biologics Sales in Volume by Region (2024-2034)
3.3.2 Global Retinal Drugs and Biologics Sales in Value by Region (2024-2034)
3.3.3 Global Retinal Drugs and Biologics Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Retinal Drugs and Biologics by Application
4.1 Retinal Drugs and Biologics Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Others
4.2 Global Retinal Drugs and Biologics Market Size by Application
4.2.1 Global Retinal Drugs and Biologics Market Size Overview by Application (2018-2034)
4.2.2 Global Retinal Drugs and Biologics Historic Market Size Review by Application (2018-2024)
4.2.3 Global Retinal Drugs and Biologics Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Retinal Drugs and Biologics Sales Breakdown by Application (2018-2024)
4.3.2 Europe Retinal Drugs and Biologics Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Retinal Drugs and Biologics Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Retinal Drugs and Biologics Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Retinal Drugs and Biologics Sales Breakdown by Application (2018-2024)
5 North America Retinal Drugs and Biologics by Country
5.1 North America Retinal Drugs and Biologics Historic Market Size by Country
5.1.1 North America Retinal Drugs and Biologics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Retinal Drugs and Biologics Sales in Volume by Country (2018-2024)
5.1.3 North America Retinal Drugs and Biologics Sales in Value by Country (2018-2024)
5.2 North America Retinal Drugs and Biologics Forecasted Market Size by Country
5.2.1 North America Retinal Drugs and Biologics Sales in Volume by Country (2024-2034)
5.2.2 North America Retinal Drugs and Biologics Sales in Value by Country (2024-2034)
6 Europe Retinal Drugs and Biologics by Country
6.1 Europe Retinal Drugs and Biologics Historic Market Size by Country
6.1.1 Europe Retinal Drugs and Biologics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Retinal Drugs and Biologics Sales in Volume by Country (2018-2024)
6.1.3 Europe Retinal Drugs and Biologics Sales in Value by Country (2018-2024)
6.2 Europe Retinal Drugs and Biologics Forecasted Market Size by Country
6.2.1 Europe Retinal Drugs and Biologics Sales in Volume by Country (2024-2034)
6.2.2 Europe Retinal Drugs and Biologics Sales in Value by Country (2024-2034)
7 Asia-Pacific Retinal Drugs and Biologics by Region
7.1 Asia-Pacific Retinal Drugs and Biologics Historic Market Size by Region
7.1.1 Asia-Pacific Retinal Drugs and Biologics Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Retinal Drugs and Biologics Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Retinal Drugs and Biologics Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Retinal Drugs and Biologics Forecasted Market Size by Region
7.2.1 Asia-Pacific Retinal Drugs and Biologics Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Retinal Drugs and Biologics Sales in Value by Region (2024-2034)
8 Latin America Retinal Drugs and Biologics by Country
8.1 Latin America Retinal Drugs and Biologics Historic Market Size by Country
8.1.1 Latin America Retinal Drugs and Biologics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Retinal Drugs and Biologics Sales in Volume by Country (2018-2024)
8.1.3 Latin America Retinal Drugs and Biologics Sales in Value by Country (2018-2024)
8.2 Latin America Retinal Drugs and Biologics Forecasted Market Size by Country
8.2.1 Latin America Retinal Drugs and Biologics Sales in Volume by Country (2024-2034)
8.2.2 Latin America Retinal Drugs and Biologics Sales in Value by Country (2024-2034)
9 Middle East and Africa Retinal Drugs and Biologics by Country
9.1 Middle East and Africa Retinal Drugs and Biologics Historic Market Size by Country
9.1.1 Middle East and Africa Retinal Drugs and Biologics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Retinal Drugs and Biologics Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Retinal Drugs and Biologics Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Retinal Drugs and Biologics Forecasted Market Size by Country
9.2.1 Middle East and Africa Retinal Drugs and Biologics Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Retinal Drugs and Biologics Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 ALLERGAN
10.1.1 ALLERGAN Company Information
10.1.2 ALLERGAN Introduction and Business Overview
10.1.3 ALLERGAN Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2018-2024)
10.1.4 ALLERGAN Retinal Drugs and Biologics Products Offered
10.1.5 ALLERGAN Recent Development
10.2 AbbVie
10.2.1 AbbVie Company Information
10.2.2 AbbVie Introduction and Business Overview
10.2.3 AbbVie Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2018-2024)
10.2.4 AbbVie Retinal Drugs and Biologics Products Offered
10.2.5 AbbVie Recent Development
10.3 Alimera Sciences
10.3.1 Alimera Sciences Company Information
10.3.2 Alimera Sciences Introduction and Business Overview
10.3.3 Alimera Sciences Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Alimera Sciences Retinal Drugs and Biologics Products Offered
10.3.5 Alimera Sciences Recent Development
10.4 Janssen Biotech
10.4.1 Janssen Biotech Company Information
10.4.2 Janssen Biotech Introduction and Business Overview
10.4.3 Janssen Biotech Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Janssen Biotech Retinal Drugs and Biologics Products Offered
10.4.5 Janssen Biotech Recent Development
10.5 Swedish Orphan Biovitrum
10.5.1 Swedish Orphan Biovitrum Company Information
10.5.2 Swedish Orphan Biovitrum Introduction and Business Overview
10.5.3 Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Swedish Orphan Biovitrum Retinal Drugs and Biologics Products Offered
10.5.5 Swedish Orphan Biovitrum Recent Development
10.6 Roche
10.6.1 Roche Company Information
10.6.2 Roche Introduction and Business Overview
10.6.3 Roche Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Roche Retinal Drugs and Biologics Products Offered
10.6.5 Roche Recent Development
10.7 Bristol-Myers Squibb
10.7.1 Bristol-Myers Squibb Company Information
10.7.2 Bristol-Myers Squibb Introduction and Business Overview
10.7.3 Bristol-Myers Squibb Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Bristol-Myers Squibb Retinal Drugs and Biologics Products Offered
10.7.5 Bristol-Myers Squibb Recent Development
10.8 Genzyme
10.8.1 Genzyme Company Information
10.8.2 Genzyme Introduction and Business Overview
10.8.3 Genzyme Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Genzyme Retinal Drugs and Biologics Products Offered
10.8.5 Genzyme Recent Development
10.9 Genentech
10.9.1 Genentech Company Information
10.9.2 Genentech Introduction and Business Overview
10.9.3 Genentech Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Genentech Retinal Drugs and Biologics Products Offered
10.9.5 Genentech Recent Development
10.10 OCULAR THERAPEUTIX
10.10.1 OCULAR THERAPEUTIX Company Information
10.10.2 OCULAR THERAPEUTIX Introduction and Business Overview
10.10.3 OCULAR THERAPEUTIX Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2018-2024)
10.10.4 OCULAR THERAPEUTIX Retinal Drugs and Biologics Products Offered
10.10.5 OCULAR THERAPEUTIX Recent Development
10.11 Bausch & Lomb
10.11.1 Bausch & Lomb Company Information
10.11.2 Bausch & Lomb Introduction and Business Overview
10.11.3 Bausch & Lomb Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Bausch & Lomb Retinal Drugs and Biologics Products Offered
10.11.5 Bausch & Lomb Recent Development
10.12 UCBCares
10.12.1 UCBCares Company Information
10.12.2 UCBCares Introduction and Business Overview
10.12.3 UCBCares Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2018-2024)
10.12.4 UCBCares Retinal Drugs and Biologics Products Offered
10.12.5 UCBCares Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Retinal Drugs and Biologics Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Retinal Drugs and Biologics Industrial Chain Analysis
11.4 Retinal Drugs and Biologics Market Dynamics
11.4.1 Retinal Drugs and Biologics Industry Trends
11.4.2 Retinal Drugs and Biologics Market Drivers
11.4.3 Retinal Drugs and Biologics Market Challenges
11.4.4 Retinal Drugs and Biologics Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Retinal Drugs and Biologics Distributors
12.3 Retinal Drugs and Biologics Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Age Related Macular Degeneration
Table 2. Major Company of Diabetic Retinopathy
Table 3. Major Company of Ocular Inflammatory Disease (Uveitis)
Table 4. Major Company of Macular Hole
Table 5. Global Retinal Drugs and Biologics Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Retinal Drugs and Biologics Sales by Type (2018-2024) & (K MT)
Table 7. Global Retinal Drugs and Biologics Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Retinal Drugs and Biologics Sales by Type (2018-2024) & (US& Million)
Table 9. Global Retinal Drugs and Biologics Market Share in Value by Type (2018-2024)
Table 10. Global Retinal Drugs and Biologics Price by Type (2018-2024) & (USD/MT)
Table 11. Global Retinal Drugs and Biologics Sales by Type (2024-2034) & (K MT)
Table 12. Global Retinal Drugs and Biologics Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Retinal Drugs and Biologics Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Retinal Drugs and Biologics Sales Market Share in Value by Type (2024-2034)
Table 15. Global Retinal Drugs and Biologics Price by Type (2024-2034) & (USD/MT)
Table 16. North America Retinal Drugs and Biologics Sales by Type (2018-2024) & (K MT)
Table 17. North America Retinal Drugs and Biologics Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Retinal Drugs and Biologics Sales (K MT) by Type (2018-2024)
Table 19. Europe Retinal Drugs and Biologics Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Retinal Drugs and Biologics Sales (K MT) by Type (2018-2024)
Table 21. Asia-Pacific Retinal Drugs and Biologics Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Retinal Drugs and Biologics Sales (K MT) by Type (2018-2024)
Table 23. Latin America Retinal Drugs and Biologics Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Retinal Drugs and Biologics Sales (K MT) by Type (2018-2024)
Table 25. Middle East and Africa Retinal Drugs and Biologics Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Retinal Drugs and Biologics Sales by Company (2018-2024) & (K MT)
Table 27. Global Retinal Drugs and Biologics Sales Share by Company (2018-2024)
Table 28. Global Retinal Drugs and Biologics Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Retinal Drugs and Biologics Revenue Share by Company (2018-2024)
Table 30. Global Market Retinal Drugs and Biologics Price by Company (2018-2024) & (USD/MT)
Table 31. Global Retinal Drugs and Biologics Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Retinal Drugs and Biologics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Retinal Drugs and Biologics as of 2022)
Table 34. Date of Key Manufacturers Enter into Retinal Drugs and Biologics Market
Table 35. Key Manufacturers Retinal Drugs and Biologics Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Retinal Drugs and Biologics Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Retinal Drugs and Biologics Sales by Region (2018-2024) & (K MT)
Table 39. Global Retinal Drugs and Biologics Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Retinal Drugs and Biologics Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Retinal Drugs and Biologics Sales Market Share in Value by Region (2018-2024)
Table 42. Global Retinal Drugs and Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 43. Global Retinal Drugs and Biologics Sales by Region (2024-2034) & (K MT)
Table 44. Global Retinal Drugs and Biologics Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Retinal Drugs and Biologics Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Retinal Drugs and Biologics Sales Market Share in Value by Region (2024-2034)
Table 47. Global Retinal Drugs and Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2024-2034)
Table 48. Global Retinal Drugs and Biologics Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Retinal Drugs and Biologics Sales by Application (2018-2024) & (K MT)
Table 50. Global Retinal Drugs and Biologics Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Retinal Drugs and Biologics Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Retinal Drugs and Biologics Sales Market Share in Value by Application (2018-2024)
Table 53. Global Retinal Drugs and Biologics Price by Application (2018-2024) & (USD/MT)
Table 54. Global Retinal Drugs and Biologics Sales by Application (2024-2034) & (K MT)
Table 55. Global Retinal Drugs and Biologics Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Retinal Drugs and Biologics Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Retinal Drugs and Biologics Sales Market Share in Value by Application (2024-2034)
Table 58. Global Retinal Drugs and Biologics Price by Application (2024-2034) & (USD/MT)
Table 59. North America Retinal Drugs and Biologics Sales by Application (2018-2024) (K MT)
Table 60. North America Retinal Drugs and Biologics Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Retinal Drugs and Biologics Sales by Application (2018-2024) (K MT)
Table 62. Europe Retinal Drugs and Biologics Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Retinal Drugs and Biologics Sales by Application (2018-2024) (K MT)
Table 64. Asia-Pacific Retinal Drugs and Biologics Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Retinal Drugs and Biologics Sales by Application (2018-2024) (K MT)
Table 66. Latin America Retinal Drugs and Biologics Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Retinal Drugs and Biologics Sales by Application (2018-2024) (K MT)
Table 68. Middle East and Africa Retinal Drugs and Biologics Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Retinal Drugs and Biologics Sales by Country (2018-2024) & (K MT)
Table 70. North America Retinal Drugs and Biologics Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Retinal Drugs and Biologics Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Retinal Drugs and Biologics Sales Market Share in Value by Country (2018-2024)
Table 73. North America Retinal Drugs and Biologics Sales by Country (2024-2034) & (K MT)
Table 74. North America Retinal Drugs and Biologics Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Retinal Drugs and Biologics Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Retinal Drugs and Biologics Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Retinal Drugs and Biologics Sales by Country (2018-2024) & (K MT)
Table 78. Europe Retinal Drugs and Biologics Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Retinal Drugs and Biologics Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Retinal Drugs and Biologics Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Retinal Drugs and Biologics Sales by Country (2024-2034) & (K MT)
Table 82. Europe Retinal Drugs and Biologics Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Retinal Drugs and Biologics Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Retinal Drugs and Biologics Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Retinal Drugs and Biologics Sales by Region (2018-2024) & (K MT)
Table 86. Asia-Pacific Retinal Drugs and Biologics Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Retinal Drugs and Biologics Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Retinal Drugs and Biologics Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Retinal Drugs and Biologics Sales by Region (2024-2034) & (K MT)
Table 90. Asia-Pacific Retinal Drugs and Biologics Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Retinal Drugs and Biologics Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Retinal Drugs and Biologics Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Retinal Drugs and Biologics Sales by Country (2018-2024) & (K MT)
Table 94. Latin America Retinal Drugs and Biologics Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Retinal Drugs and Biologics Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Retinal Drugs and Biologics Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Retinal Drugs and Biologics Sales by Country (2024-2034) & (K MT)
Table 98. Latin America Retinal Drugs and Biologics Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Retinal Drugs and Biologics Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Retinal Drugs and Biologics Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Retinal Drugs and Biologics Sales by Country (2018-2024) & (K MT)
Table 102. Middle East and Africa Retinal Drugs and Biologics Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Retinal Drugs and Biologics Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Retinal Drugs and Biologics Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Retinal Drugs and Biologics Sales by Country (2024-2034) & (K MT)
Table 106. Middle East and Africa Retinal Drugs and Biologics Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Retinal Drugs and Biologics Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Retinal Drugs and Biologics Sales Market Share in Value by Country (2024-2034)
Table 109. ALLERGAN Company Information
Table 110. ALLERGAN Introduction and Business Overview
Table 111. ALLERGAN Retinal Drugs and Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 112. ALLERGAN Retinal Drugs and Biologics Product
Table 113. ALLERGAN Recent Development
Table 114. AbbVie Company Information
Table 115. AbbVie Introduction and Business Overview
Table 116. AbbVie Retinal Drugs and Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 117. AbbVie Retinal Drugs and Biologics Product
Table 118. AbbVie Recent Development
Table 119. Alimera Sciences Company Information
Table 120. Alimera Sciences Introduction and Business Overview
Table 121. Alimera Sciences Retinal Drugs and Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 122. Alimera Sciences Retinal Drugs and Biologics Product
Table 123. Alimera Sciences Recent Development
Table 124. Janssen Biotech Company Information
Table 125. Janssen Biotech Introduction and Business Overview
Table 126. Janssen Biotech Retinal Drugs and Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 127. Janssen Biotech Retinal Drugs and Biologics Product
Table 128. Janssen Biotech Recent Development
Table 129. Swedish Orphan Biovitrum Company Information
Table 130. Swedish Orphan Biovitrum Introduction and Business Overview
Table 131. Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 132. Swedish Orphan Biovitrum Retinal Drugs and Biologics Product
Table 133. Swedish Orphan Biovitrum Recent Development
Table 134. Roche Company Information
Table 135. Roche Introduction and Business Overview
Table 136. Roche Retinal Drugs and Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 137. Roche Retinal Drugs and Biologics Product
Table 138. Roche Recent Development
Table 139. Bristol-Myers Squibb Company Information
Table 140. Bristol-Myers Squibb Introduction and Business Overview
Table 141. Bristol-Myers Squibb Retinal Drugs and Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 142. Bristol-Myers Squibb Retinal Drugs and Biologics Product
Table 143. Bristol-Myers Squibb Recent Development
Table 144. Genzyme Company Information
Table 145. Genzyme Introduction and Business Overview
Table 146. Genzyme Retinal Drugs and Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 147. Genzyme Retinal Drugs and Biologics Product
Table 148. Genzyme Recent Development
Table 149. Genentech Company Information
Table 150. Genentech Introduction and Business Overview
Table 151. Genentech Retinal Drugs and Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 152. Genentech Retinal Drugs and Biologics Product
Table 153. Genentech Recent Development
Table 154. OCULAR THERAPEUTIX Company Information
Table 155. OCULAR THERAPEUTIX Introduction and Business Overview
Table 156. OCULAR THERAPEUTIX Retinal Drugs and Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 157. OCULAR THERAPEUTIX Retinal Drugs and Biologics Product
Table 158. OCULAR THERAPEUTIX Recent Development
Table 159. Bausch & Lomb Company Information
Table 160. Bausch & Lomb Introduction and Business Overview
Table 161. Bausch & Lomb Retinal Drugs and Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 162. Bausch & Lomb Retinal Drugs and Biologics Product
Table 163. Bausch & Lomb Recent Development
Table 164. UCBCares Company Information
Table 165. UCBCares Introduction and Business Overview
Table 166. UCBCares Retinal Drugs and Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 167. UCBCares Retinal Drugs and Biologics Product
Table 168. UCBCares Recent Development
Table 169. Key Raw Materials Lists
Table 170. Raw Materials Key Suppliers Lists
Table 171. Retinal Drugs and Biologics Market Trends
Table 172. Retinal Drugs and Biologics Market Drivers
Table 173. Retinal Drugs and Biologics Market Challenges
Table 174. Retinal Drugs and Biologics Market Restraints
Table 175. Retinal Drugs and Biologics Distributors List
Table 176. Retinal Drugs and Biologics Downstream Customers
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. Retinal Drugs and Biologics Product Picture
Figure 2. Global Retinal Drugs and Biologics Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Retinal Drugs and Biologics Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Retinal Drugs and Biologics Sales Status and Outlook (2018-2034) & (K MT)
Figure 5. Product Picture of Age Related Macular Degeneration
Figure 6. Global Age Related Macular Degeneration Sales YoY Growth (2018-2034) & (K MT)
Figure 7. Product Picture of Diabetic Retinopathy
Figure 8. Global Diabetic Retinopathy Sales YoY Growth (2018-2034) & (K MT)
Figure 9. Product Picture of Ocular Inflammatory Disease (Uveitis)
Figure 10. Global Ocular Inflammatory Disease (Uveitis) Sales YoY Growth (2018-2034) & (K MT)
Figure 11. Product Picture of Macular Hole
Figure 12. Global Macular Hole Sales YoY Growth (2018-2034) & (K MT)
Figure 13. Global Retinal Drugs and Biologics Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Retinal Drugs and Biologics Sales Market Share by Type in 2022 & 2034
Figure 15. North America Retinal Drugs and Biologics Sales Market Share in Volume by Type in 2022
Figure 16. North America Retinal Drugs and Biologics Sales Market Share in Value by Type in 2022
Figure 17. Europe Retinal Drugs and Biologics Sales Market Share in Volume by Type in 2022
Figure 18. Europe Retinal Drugs and Biologics Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Retinal Drugs and Biologics Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Retinal Drugs and Biologics Sales Market Share in Value by Type in 2022
Figure 21. Latin America Retinal Drugs and Biologics Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Retinal Drugs and Biologics Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Retinal Drugs and Biologics Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Retinal Drugs and Biologics Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Retinal Drugs and Biologics Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Retinal Drugs and Biologics Revenue in 2022
Figure 27. Retinal Drugs and Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Hospitals
Figure 29. Global Hospitals Sales YoY Growth (2018-2034) & (K MT)
Figure 30. Product Picture of Clinics
Figure 31. Global Clinics Sales YoY Growth (2018-2034) & (K MT)
Figure 32. Product Picture of Others
Figure 33. Global Others Sales YoY Growth (2018-2034) & (K MT)
Figure 34. Global Retinal Drugs and Biologics Sales by Application (2018-2034) & (US$ Million)
Figure 35. Global Retinal Drugs and Biologics Sales Market Share by Application in 2022 & 2034
Figure 36. North America Retinal Drugs and Biologics Sales Market Share in Volume by Application in 2022
Figure 37. North America Retinal Drugs and Biologics Sales Market Share in Value by Application in 2022
Figure 38. Europe Retinal Drugs and Biologics Sales Market Share in Volume by Application in 2022
Figure 39. Europe Retinal Drugs and Biologics Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Retinal Drugs and Biologics Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Retinal Drugs and Biologics Sales Market Share in Value by Application in 2022
Figure 42. Latin America Retinal Drugs and Biologics Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Retinal Drugs and Biologics Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Retinal Drugs and Biologics Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Retinal Drugs and Biologics Manufacturing Cost Structure
Figure 47. Retinal Drugs and Biologics Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries